News
Biocon consolidated net profit declines 63.45% in the March 2026 quarter
08-May-2026 | 08:59
Sales rise 2.90% to Rs 4484.30 crore
Net profit of Biocon declined 63.45% to Rs 125.90 crore in the quarter ended March 2026 as against Rs 344.50 crore during the previous quarter ended March 2025. Sales rose 2.90% to Rs 4484.30 crore in the quarter ended March 2026 as against Rs 4358.10 crore during the previous quarter ended March 2025.
For the full year,net profit declined 61.95% to Rs 385.60 crore in the year ended March 2026 as against Rs 1013.30 crore during the previous year ended March 2025. Sales rose 11.48% to Rs 16779.90 crore in the year ended March 2026 as against Rs 15052.20 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 4484.30 | 4358.10 | 3 | 16779.90 | 15052.20 | 11 |
| OPM % | 22.75 | 24.74 | - | 20.59 | 21.04 | - |
| PBDT | 841.30 | 902.70 | -7 | 2807.50 | 3477.10 | -19 |
| PBT | 327.90 | 466.40 | -30 | 850.80 | 1790.10 | -52 |
| NP | 125.90 | 344.50 | -63 | 385.60 | 1013.30 | -62 |
Powered by Capital Market - Live News
